Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of IHCs Treated With Pegylated Interferon α2b Based on Pulse Theray or Sequential Therapy

NCT05457920 is registered in ClinicalTrials.gov with Henan Provincial People's Hospital as lead sponsor.

NCT NCT05457920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of IHCs Treated With Pegylated Interferon α2b Based on Pulse Theray or Sequential Therapy
Lead sponsor
Henan Provincial People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2021
Completion date
September 30, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b